Somani S M, Anderson J H
Drug Metab Dispos. 1975 Jul-Aug;3(4):275-82.
Isolated rat livers were perfused with 0.9 to 18 mumol of 14C-neostigmine (NEO) or 14C-(3-hydroxyphenyl)trimethylammonium (HPTMA). Within 30 min. 30-90% of the administered doses were sequestered by the liver. The initial extraction rate was equivalent to about 15% of the perfusion rate. There was no evidence for saturation of the rate or the extent of sequestration of NEO or HPTMA over the dosage range examined. The amount of radioactivity in the liver remained relatively constant for several hours while NEO was converted to HPTMA and its glucuronide (G-HPTMA), plus small amounts of other metabolites. HPTMA rapidly appeared in the perfusate, but there was about an hour lag in the appearance of G-HPTMA. The concentrations of NEO and major metabolites were generally higher in the liver than in the perfusate.
用0.9至18微摩尔的14C-新斯的明(NEO)或14C-(3-羟基苯基)三甲基铵(HPTMA)灌注离体大鼠肝脏。在30分钟内,肝脏摄取了给药剂量的30%至90%。初始提取率约相当于灌注率的15%。在所研究的剂量范围内,没有证据表明NEO或HPTMA的摄取速率或摄取程度会饱和。在NEO转化为HPTMA及其葡糖醛酸化物(G-HPTMA)以及少量其他代谢产物的过程中,肝脏中的放射性量在数小时内保持相对恒定。HPTMA迅速出现在灌注液中,但G-HPTMA的出现大约有1小时的延迟。肝脏中NEO和主要代谢产物的浓度通常高于灌注液中的浓度。